The novel antiarrhythmic drug dronedarone: Comparison with amiodarone

Cardiovascular Drug Reviews

Volumn 23, Issue 3, 2005, Pages 217-230

  Kathofer, Sven ^a   Thomas, Dierk ^a   Karle, Christoph A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Amiodarone; Antiarrhythmics; Arrhythmias; Dronedarone; Hyperthyroidism; Hypothyroidism; QT syndrome; Torsades de pointes

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BENZOFURAN DERIVATIVE; DRONEDARONE; PLACEBO; THYROID HORMONE;

ADRENERGIC ACTIVITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ELECTROPHYSIOLOGY; EYE TOXICITY; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IN VIVO STUDY; ISCHEMIA; LIVER TOXICITY; LONG QT SYNDROME; LUNG TOXICITY; NAUSEA; NEUROTOXICITY; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RELAPSE; REPERFUSION INJURY; REVIEW; SIDE EFFECT; SODIUM CURRENT; THYROID FUNCTION; TORSADE DES POINTES; TREATMENT OUTCOME; VOMITING;

EID: 27644459678     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2005.tb00167.x     Document Type: Review

References (40)

1. Aimond F, Beck L, Gautier P, et al. Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats. J Pharmacol Exp Ther 2000;292:415-424.
2. Altomare C, Barbuti A, Viscomi C, Baruscotti M, DiFrancesco D. Effects of dronedarone on acetylcholine-activated current in rabbit SAN cells. Br J Pharmacol 2000;130:1315-1320.
3. Chatelain P, Meysmans L, Matteazzi JR, Beaufort P, Clinet M. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol 1995;116:1949-1956.
4. Cluzel M. ANDROMEDA study discontinuation. Sanofi-Synthelabo; Merrill Lynch global pharmaceutical conference. 24 September 2003, company website.
5. Damy T, Pousset F, Caplain H, Hulot JS, Lechat P. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects. Fundam Clin Pharmacol 2004;18:113-123.
6. Djandjighian L, Planchenault J, Finance O, Pastor G, Gautier P, Nisato D. Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction. J Cardiovasc Pharmacol 2000;36:376-383.
7. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788.
8. Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D, L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 1995;26:570-576.
9. Gautier P, Guillemare E, Marion A, Bertrand JP, Tourneur Y, Nisato D. Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. J Cardiovasc Pharmacol 2003;41:191-202.
10. + pump in rabbit cardiac myocytes after acute and chronic treatment. J Pharmacol Exp Ther 1998;284:75-82.
11. + current in guinea pig atrial cells. J Cardiovasc Pharmacol 2000;36:802-805.
12. Guiraudou P, Pucheu SC, Gayraud R, et al. Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart. Eur J Pharmacol 2004;496:119-127.
13. Haffajee CI. Clinical pharmacokinetics of amiodarone. Clin Cardiol 1987;10(Suppl 1):I6-I9.
14. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983;67:1347-1355.
15. Hohnloser SH. EURIDIS and ADONIS (maintenance of sinus rhythm with dronedarone in patients with atrial fibrillation or flutter). Clin Cardiol 2004;27:660-664.
16. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic events. A review with special reference to torsade de pointes arrhythmia. Ann Intern Med 1994;121:529-535.
17. Kowey PR, Yan GX, Winkel E, Kao W. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: Guideline-based and new approaches. Am J Cardiol 2003;91 (Suppl):33D-38D.
18. Lalevee N, Nargeot J, Barrere-Lemarie S, Gautier P, Richard S. Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol 2003;14:885-890.
19. Manning AS, Bruyninckx C, Ramboux J, Chatelain P. SR 33589, a new amiodarone-like agent: Effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 1995;26:453-461.
20. Manning A, Thisse V, Hodeige D, Richard J, Heyndrickx JP, Chatelain P. SR 33589, a new amiodarone-like antiarrhythmic agent: Electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 1995;25:252-261.
21. Naccarelli GV, Wolbrette DL, Patel HM, Luck JC. Amiodarone: Clinical trials. Curr Opin Cardiol 2000;15:64-72.
22. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaing sinus rhythm in atrial fibrillation: Comparative efficacy and results of trials. Am J Cardiol 2003;91(Suppl):15D-26D.
23. Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions. Br J Clin Pharmacol 2000;49:244-253.
24. Pantos C, Mourouzis I, Delbruyere M, et al. Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart. Eur J Pharmacol 2004;444:191-196.
25. + pump in rabbit cardiac myocytes is thyroid-dependent: Comparison with dronedarone. Cardiovasc Res 2003;57:101-108.
26. Podrid PJ. Amiodarone: Reevaluation of an old drug. Ann Intern Med 1995;122:689-700.
27. Pollak PT, Bouillon T, Shafer SL. Population pharmacokinetics of long-term oral amiodarone therapy. Clin Pharmacol Ther 2000;67:642-652.
28. Quaglino D, Ha HR, Duner E, et al. Effects of metabolites and analogs of amiodarone on alveolar macrophages: Structure-activity relationship. Am J Physiol Lung Cell Mol Physiol 2004;287:L438-L447.
29. + channel blockade by the antiarrhythmic agent dronedarone: Resistance to mutations of the S6 residues Y652 and F656. Biochem Biophys Res Commun 2004;325:883-891.
30. Rochetaing A, Barbe C, Kreher P. Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. J Cardiovasc Pharmacol 2001;38:500-511.
31. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.
32. Sanofi-Aventis. Discontinuation of one of the studies (ANDROMEDA) with dronedarone. 17 January 2003; press release.
33. Sun W, Sarma JS, Singh BN. Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: Comparison with amiodarone. Circulation 1999;100:2276-2281.
34. Sun W, Sarma JS, Singh BN. Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: Comparison with amiodarone. J Cardiovasc Pharmacol 2002;39:677-684.
35. + current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol 2004;140:996-1002.
36. Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J 2003;24:1481-1487.
37. 1: In vitro and in vivo evidence. Endocrinology 2003;144:552-558.
38. van Opstal JM, Schoenmakers M, Verduyn SC, et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 2001;104:2722-2727.
39. Varro A, Takacs J, Nemeth M, et al. Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: Comparison with amiodarone. Br J Pharmacol 2001;133:625-634.
40. Verduyn SC, Vos MA, Leunissen HD, van Opstal JM, Wellens HJ. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias. J Cardiovasc Pharmacol 1999;33:212-222.